Oxford Asset Management’s Fortress Biotech FBIO Stock Holding History

Oxford Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$133K	Sell	4,691 -11,594	-71%	-$385K	0.02%	131
2019 Q4	$628K	Buy	16,285 +12,442	+324%	+$319K	0.02%	1120
2019 Q3	$81K	Buy	+3,843	New	+$90.4K	﹤0.01%	1637
2019 Q1	–	Sell	-2,911	Closed	-$38K	–	1755
2018 Q4	$38K	Buy	+2,911	New	+$48.6K	﹤0.01%	1721
2018 Q1	–	Sell	-768	Closed	-$46K	–	1694
2017 Q4	$46K	Buy	+768	New	+$45.2K	﹤0.01%	1564
2016 Q3	–	Sell	-726	Closed	-$29K	–	790
2016 Q2	$29K	Buy	+726	New	+$33.8K	﹤0.01%	773
2015 Q3	–	Sell	-6,650	Closed	-$335K	–	653
2015 Q2	$335K	Buy	6,650 +631	+10%	+$32.4K	0.01%	556
2015 Q1	$348K	Buy	+6,019	New	+$251K	0.01%	569
2014 Q1	–	Sell	-22,646	Closed	-$893K	–	678
2013 Q4	$893K	Buy	22,646 +12,518	+124%	+$483K	0.02%	531
2013 Q3	$1.07M	Buy	+10,128	New	+$1.24M	0.02%	572

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

Oxford Asset Management's FBIO Position: Q1 2020 in Review

Oxford Asset Management reduced its Fortress Biotech (FBIO) stake by 71% in Q1 2020, selling an estimated $385K and leaving 4,691 shares worth $133K. The position accounts for 0.02% of the portfolio, ranked #131.

Oxford Asset Management first reported a position in FBIO in Q3 2013 and has held it in 10 quarters since. The position peaked at $1.07M in Q3 2013. 55 funds tracked by Wall St. Rank hold FBIO as of Q1 2020.

Oxford Asset Management held 4,691 shares of Fortress Biotech worth $133K as of Q1 2020.
Oxford Asset Management sold 11,594 Fortress Biotech shares in Q1 2020, an estimated $385K.
Fortress Biotech made up 0.02% of Oxford Asset Management's portfolio in Q1 2020, its #131 holding.
Oxford Asset Management first reported a position in Fortress Biotech in Q3 2013 and has held it in 10 quarters since.
Oxford Asset Management's Fortress Biotech position peaked at $1.07M in Q3 2013.
55 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.